Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors
Cardinal Health (CAH) concluded the recent trading session at $96.01, signifying a -0.9% move from its prior day's close.
Cardinal Health (CAH) Recalls Kits Containing Shenli's Syringes
Cardinal Health (CAH) recalls its procedure kits that contain plastic syringes manufactured by a Chinese manufacturer, Jiangsu Shenli.
Cardinal Health: Growing Into The Valuation
Cardinal Health is a market leader in healthcare with stable revenue streams and growth opportunities, despite being potentially overvalued. Recent performance shows solid revenue and profit growth, but valuation metrics suggest potential overvaluation compared to sector averages. Growth drivers include expansion in specialty pharmaceuticals, biosimilars market, and emerging healthcare segments, with a focus on operational efficiency and customer value propositions.
5 Upcoming Dividend Increases Including A King
This week's increases include Dividend King Sysco Corporation with a 2% increase, extending its 54-year streak. The tables and lists are generated using data from the U.S. Dividend Champions spreadsheet and NASDAQ. I review some companies closer as part of my review process for including them in my own personal portfolio.
5 Cheap Stocks Buying Back Shares at Reasonable Prices
Buybacks are in fashion. But at today's valuations, companies could be paying up for their own stock—and that's never a good idea, whether you're a CEO or a retail investor.
Cardinal Health, Inc. (CAH) Leerink Partners Healthcare Crossroads Conference (Transcript)
Cardinal Health, Inc. (NYSE:CAH ) Leerink Partners Healthcare Crossroads Conference May 29, 2024 10:00 AM ET Company Participants Matt Sims - Head, IR Aaron Alt - CFO Conference Call Participants Michael Cherny - Leerink Partners Michael Cherny Great. We'll get started now.
Here's Why Cardinal Health (CAH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now
Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. Gross margins improve.
Investors Heavily Search Cardinal Health, Inc. (CAH): Here is What You Need to Know
Cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
